Updated projections of future vCJD deaths in the UK

<p>Abstract</p> <p>Background</p> <p>Past projections of the future course of the vCJD epidemic in the UK have shown considerable uncertainty, with wide confidence bounds. However, recent vCJD case data have indicated a decrease in the annual incidence of deaths over th...

Full description

Bibliographic Details
Main Authors: Ferguson Neil M, Donnelly Christl A, Ghani Azra C, Anderson Roy M
Format: Article
Language:English
Published: BMC 2003-04-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/3/4
id doaj-483f400e028a4422bc973c69c6e8689b
record_format Article
spelling doaj-483f400e028a4422bc973c69c6e8689b2020-11-25T01:42:59ZengBMCBMC Infectious Diseases1471-23342003-04-0131410.1186/1471-2334-3-4Updated projections of future vCJD deaths in the UKFerguson Neil MDonnelly Christl AGhani Azra CAnderson Roy M<p>Abstract</p> <p>Background</p> <p>Past projections of the future course of the vCJD epidemic in the UK have shown considerable uncertainty, with wide confidence bounds. However, recent vCJD case data have indicated a decrease in the annual incidence of deaths over the past two years.</p> <p>Methods</p> <p>A detailed survival model is fitted to the 121 vCJD deaths reported by the end of 2002 stratified by age and calendar time to obtain projections of future incidence. The model is additionally fitted to recent results from a survey of appendix tissues.</p> <p>Results</p> <p>Our results show a substantial decrease in the uncertainty of the future course of the primary epidemic in the susceptible genotype (MM-homozygous at codon 129 of the prion protein gene), with a best estimate of 40 future deaths (95% prediction interval 9–540) based on fitting to the vCJD case data alone. Additional fitting of the appendix data increases these estimates (best estimate 100, 95% prediction interval 10–2,600) but remains lower than previous projections.</p> <p>Conclusions</p> <p>The primary vCJD epidemic in the known susceptible genotype in the UK appears to be in decline.</p> http://www.biomedcentral.com/1471-2334/3/4
collection DOAJ
language English
format Article
sources DOAJ
author Ferguson Neil M
Donnelly Christl A
Ghani Azra C
Anderson Roy M
spellingShingle Ferguson Neil M
Donnelly Christl A
Ghani Azra C
Anderson Roy M
Updated projections of future vCJD deaths in the UK
BMC Infectious Diseases
author_facet Ferguson Neil M
Donnelly Christl A
Ghani Azra C
Anderson Roy M
author_sort Ferguson Neil M
title Updated projections of future vCJD deaths in the UK
title_short Updated projections of future vCJD deaths in the UK
title_full Updated projections of future vCJD deaths in the UK
title_fullStr Updated projections of future vCJD deaths in the UK
title_full_unstemmed Updated projections of future vCJD deaths in the UK
title_sort updated projections of future vcjd deaths in the uk
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2003-04-01
description <p>Abstract</p> <p>Background</p> <p>Past projections of the future course of the vCJD epidemic in the UK have shown considerable uncertainty, with wide confidence bounds. However, recent vCJD case data have indicated a decrease in the annual incidence of deaths over the past two years.</p> <p>Methods</p> <p>A detailed survival model is fitted to the 121 vCJD deaths reported by the end of 2002 stratified by age and calendar time to obtain projections of future incidence. The model is additionally fitted to recent results from a survey of appendix tissues.</p> <p>Results</p> <p>Our results show a substantial decrease in the uncertainty of the future course of the primary epidemic in the susceptible genotype (MM-homozygous at codon 129 of the prion protein gene), with a best estimate of 40 future deaths (95% prediction interval 9–540) based on fitting to the vCJD case data alone. Additional fitting of the appendix data increases these estimates (best estimate 100, 95% prediction interval 10–2,600) but remains lower than previous projections.</p> <p>Conclusions</p> <p>The primary vCJD epidemic in the known susceptible genotype in the UK appears to be in decline.</p>
url http://www.biomedcentral.com/1471-2334/3/4
work_keys_str_mv AT fergusonneilm updatedprojectionsoffuturevcjddeathsintheuk
AT donnellychristla updatedprojectionsoffuturevcjddeathsintheuk
AT ghaniazrac updatedprojectionsoffuturevcjddeathsintheuk
AT andersonroym updatedprojectionsoffuturevcjddeathsintheuk
_version_ 1725033753977290752